Industry News & Updates

A major new study shows that cannabis containing microdosed THC can significantly reduce chronic lower-back pain, without the dependency risks of opioids. By stimulating CB1 and CB2 receptors together, cannabis may offer the most effective relief for millions struggling with pain. Could this be the future of chronic pain management?

Federal cannabis reform appears to be retreating, with House Republicans pushing Section 607 to block rescheduling efforts and Trump signaling only lip service at high-dollar fundraisers. Meanwhile, veterans and patients are left waiting as U.S. growers watch Canadian imports take the stage.

As the NFL season begins, cannabis is taking center stage for both players and fans. With the NFLPA raising THC limits, athletes gain recovery options while fans embrace cannabis on game day. This blog explores the future of cannabis in sports and its business potential.

Last week, Donald Trump signaled he is considering rescheduling cannabis from Schedule 1 - a classification shared with heroin and deemed more dangerous than cocaine - to Schedule 3, where prescription drugs like Tylenol with codeine reside. This move could open the door to normalized banking, credit card payments at dispensaries, greater patient access, and potentially unlock sidelined investment capital. U.S. cannabis stocks reacted immediately, with some rising nearly 100%

A massive ICE raid on California’s largest cannabis farm sparks violence, injuries, and urgent questions about ICE raids, labor, and compliance.

California’s cannabis industry is in crisis, but crisis can be the turning point. Tax burdens, policy failures, and crashing valuations mark a hard reset. Yet with unmatched legacy, climate, and culture, California can rise again—stronger, smarter, and ready to lead the nation’s cannabis future.

420 lands on Easter as tariffs rise—a sign to resurrect the domestic cannabis industry High Holy Days This year, a haze of coincidence...